The Polish health protection system is currently poorly prepared for crisis situations, such as further pandemics or natural disasters. Essentially, every element needs improvement:...
At the start of 2024, AstraZeneca finalized the purchase of two biotechnological companies conducting advanced clinical research in the field of oncology, autoimmune diseases,...
In 2023, AstraZeneca invested approximately 15 million PLN in preventive and diagnostic measures in Poland. This amount was significantly higher than the sum declared...